Answers are grounded in this paper and cite their sources.
Background: Reverse transcription loop-mediated isothermal amplification (RT-LAMP) offers a rapid, point-of-care alternative to RT-qPCR, yet direct molecular testing of clinical specimens is limited by sample matrix inhibition and target RNA degradation. Methods: We evaluated the diagnostic performance and stabilization efficiency of exogenous carrier yeast transfer RNA (tRNA) in colorimetric and fluorometric RT-qLAMP, using SARS-CoV-2 clinical specimens stored in viral transport medium (VTM) as a model. VTM carryover was optimized via sample dilution, and clinical specimens were subjected to thermal stress (37 °C for 3 and 15 days) with or without 1 µg/µL yeast tRNA. Results: Restricting VTM carryover to 1% (v/v) via sample dilution successfully eliminated matrix inhibition, yielding rapid time-to-positivity (Tp) and good correlation with reference RT-qPCR cycle threshold (Ct) metrics. Under thermal stress, VTM preserved viral RNA remarkably well, showing negligible kinetic loss at 3 days and only minor Tp delays after 15 days of continuous heat exposure. Notably, exogenous yeast tRNA supplementation conferred no additional protective benefit against thermal degradation compared to VTM alone. Conclusions: In our tested conditions, commercial VTM inherently safeguards viral target integrity under ambient thermal stress without requiring supplementary carrier RNA.
No takes yet. Share an insight, caveat, or question.
Morais‐Armas et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: